Geriatric syndromes. how to treat by Cesari, Matteo et al.
Full Terms & Conditions of access and use can be found at
http://www.tandfonline.com/action/journalInformation?journalCode=kvir20
Download by: [2.231.136.104] Date: 21 August 2016, At: 12:56
Virulence
ISSN: 2150-5594 (Print) 2150-5608 (Online) Journal homepage: http://www.tandfonline.com/loi/kvir20
Geriatric syndromes: How to treat
Matteo Cesari MD, PhD, Emanuele Marzetti, Marco Canevelli & Giovanni
Guaraldi
To cite this article: Matteo Cesari MD, PhD, Emanuele Marzetti, Marco Canevelli
& Giovanni Guaraldi (2016): Geriatric syndromes: How to treat, Virulence, DOI:
10.1080/21505594.2016.1219445
To link to this article:  http://dx.doi.org/10.1080/21505594.2016.1219445
Accepted author version posted online: 11
Aug 2016.
Published online: 11 Aug 2016.
Submit your article to this journal 
Article views: 40
View related articles 
View Crossmark data
REVIEW
Geriatric syndromes: How to treat
Matteo Cesaria,b, Emanuele Marzettic, Marco Canevellid, and Giovanni Guaraldie
aGerontopo^le, Centre Hospitalier Universitaire de Toulouse, Toulouse, France; bUniversite de Toulouse III Paul Sabatier, Toulouse, France;
cDepartment of Geriatrics, Neurosciences and Orthopedics, Catholic University of the Sacred Heart, Rome, Italy; dMemory Clinic, Department of
Neurology and Psychiatry, Sapienza University, Rome, Italy; eDepartment of Medical and Surgical Sciences for Adults and Children, Clinic of
Infectious Diseases, University of Modena and Reggio Emilia, Modena, Italy
ARTICLE HISTORY
Received 25 March 2016
Revised 26 July 2016
Accepted 27 July 2016
ABSTRACT
The survival of HIV-infected persons has been increasing over the last years, thanks to the
implementation of more effective pharmacological and non-pharmacological interventions.
Nevertheless, HIV-infected persons are often “biologically” older than their “chronological” age due
to multiple clinical, social, and behavioral conditions of risk. The detection in this population of
specific biological features and syndromic conditions typical of advanced age has made the HIV
infection an interesting research model of accelerated and accentuated aging. Given such
commonalities, it is possible that “biologically aged” HIV-positive persons might benefit from
models of adapted and integrated care developed over the years by geriatricians for the
management of their frail and complex patients.
In this article, possible strategies to face the increasingly prevalent geriatric syndromes in HIV-
infected persons are discussed. In particular, it is explained the importance of shifting from the
traditional disease-oriented approach into models of care facilitating a multidisciplinary
management of frailty.
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Global aging and changing scenarios
The demographic changes occurring worldwide are
exposing the current models of healthcare to the risk of
collapsing.1 Patients that are today usually seen in clini-
cal services are indeed very different from those for
whom the same services were designed decades ago.
Nowadays, the daily clinical routine is mostly absorbed
by the assessment and treatment of patients character-
ized by older age, more comorbidities and syndromes,
and higher consumption of medications.2
This transition is evident across most medical disci-
plines, including infectious disease medicine (IDM).
Indeed, with the widespread implementation of highly
active antiretroviral therapy (HAART), the survival of
HIV-infected persons has been substantially extended,
approaching that of the general population in high-
income countries.3 At the same time, specific pathophys-
iological features brought about by HIV infection have
led to considering it a model of accelerated and accentu-
ated aging,4 and a condition of possible use for develop-
ing strategies against age-related conditions.5 Indeed,
HIV-positive patients can often be considered “old and
frail” under a biological viewpoint, although still “young”
if the obsolete chronological age criterion is used as
reference.
It is not far from reality saying that multiple disci-
plines sharing this same problem are today looking with
increasing interest to the background and specificities of
geriatric medicine. This is not surprising because the his-
torical background of geriatricians has always been cen-
tered on the management of frail and complex elders. In
this context, geriatric medicine has been contributing
over the years with the development of specific strategies
and methodologies (although not always correctly inter-
preted and applied).6
It is noteworthy that the nosographic entities at the
basis of traditional medicine tend to lose their meaning
and relevance with advancing age. The simultaneous
presence of multiple and interacting clinical and subclin-
ical conditions in the older individual leads to heteroge-
neous phenotypic manifestations, which are often not
attributable to any of the single conditions the person
suffers from. In such a scenario, the concept of “stand-
alone” diseases (all individually targetable with specific
interventions) is therefore not applicable in contempo-
rary medicine. Indeed, by focusing the medical attention
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on individual diagnoses and treating each of them
according to standard protocols and guidelines, the over-
all picture of the patient would be ineluctably lost, easily
resulting in over-diagnosis and/or over-treatment.
A related problem is the lack of randomized con-
trolled trials recruiting participants with the characteris-
tics and complexities of the average patient attending
clinical services. This means doubting and arguing the
appropriateness of standard protocols and decisional
algorithms traditionally used in medicine.7 This issue
may potentially drive toward the opposite condition of
over-diagnosis and over-treatment, which is “ageism”
and preclusion from therapeutic options.
In the present article, we discuss the possible treat-
ment strategies that can be adopted to face the increas-
ingly prevalent geriatric syndromes in clinical settings.
In the first section, the need of reshaping the models of
care is linked to the geriatric condition of frailty. Frailty
is often described as a syndrome and for this reason
included in the present document. However, we believe
that frailty is something more than that and could repre-
sent the umbrella under which conducting the clinical
care of geriatric conditions and syndromes. In the second
part of the article, we show how frequently major geriat-
ric syndromes occur in HIV-positive patients, and sug-
gest possible ad hoc solutions developed by geriatricians
over the years.
Frailty: A mere syndrome or a cornerstone
condition for remodeling healthcare services?
A geriatric syndrome is a non-disease clinical condition
of older persons characterized by multiple causes deter-
mining a unified manifestation. By definition, it encom-
passes a group of signs and symptoms variably occurring
together and characterizing a particular abnormality.
This implies that geriatric syndromes present a multifac-
torial and extremely heterogeneous background, ground-
ing its roots in clinical, psychological, social, and
environmental vulnerabilities.8
As previously argued, in a world experiencing the
consequences of global aging (even in low-income coun-
tries), the traditional concept of advanced age to define
the “older” individual is no longer effective. The current
clinical reality calls for new paradigms that are able to
offer more accurate and personalized care. Such a transi-
tion may be accomplished through the quantification of
the homeostatic reserves of the organism in order to
obtain an estimate of its “biological age.” This is the
main reason why geriatric medicine started developing
specific activities around the so-called “frailty” condition.
Frailty (defined as a condition of increased vulnerabil-
ity due to the reduction of homeostatic reserves,
exposing the individual to higher risk of negative out-
comes) is sometimes presented as a syndrome,9 some
others as a state of health determined by the age-related
accumulation of deficits.10 Such ambiguity largely
depends on the operational definition adopted to frame
it.11 In fact, frailty is frequently described as a syndrome
because associated with the widely diffused model pro-
posed by Fried and colleagues.12 The so-called frailty
phenotype based on the assessment of 5 epidemiologi-
cally-derived criteria (i.e., poor muscle strength, slow
gait speed, exhaustion, sedentary behavior, and involun-
tary weight loss) clearly describes frailty as a syndrome.
However, the automatic translation of a condition with
an instrument designed for measuring it should be cau-
tious because highly arguable. In particular, by doing the
equivalence between frailty and frailty phenotype, several
aspects are neglected:
1) Frailty existed and was treated in geriatric medicine
well before the development of the frailty pheno-
type from the Cardiovascular Health Study
database;13
2) The instrument was designed with the properties of
a screening tool;11 and as such it is unable to ade-
quately support the design of interventions against
the underlying causes of frailty;
3) Many other instruments are available that similarly
identify older persons at increased risk of negative
health-related outcomes, sometimes even in an eas-
ier and more reproducible way;14,15
4) The detrimental consequences of frailty in the
older individual frequently find their causes in
domains beyond the physical dimension;16 and
5) Adding the notion of frailty to a standard clinical
assessment has very modest relevance if the infor-
mation is not translated into a specific counterac-
tion (obviously not doable on the basis of the result
of a screening test).17
Differently, if frailty is more broadly considered a
continuous parameter reflecting the “biological aging” of
the individual, it might represent much more than a
mere condition to be screened. It may indeed assert to
the criterion for taking decisions of public health rele-
vance.16 In fact, if we disregard the concept of frailty as a
syndrome and start looking at it as a point in the contin-
uous process of aging, it will be possible to use it to
replace the obsolete criterion of chronological age in
clinical decisional algorithms. To put it differently,
instead of talking of older persons in terms of years of
life lived, we might focus the concept of aging on the
clinical and biological features determining the vulnera-
bility of the older individual. This reasoning might
directly affect the allocation of resources, which would
be used to cover different needs in a “biologically young”
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person of 80 y of age (suitable for traditional medical
paradigms and protocols) versus a “biologically old”
individual of 50 (as frequently occurring among HIV-
positive patients).
The incorporation of frailty assessment in clinical
practice might take advantage of the large and increasing
diffusion of the frailty concept across medical specialties.
Frailty is no longer an exclusivity of geriatricians and
gerontologists. Having multiple disciplines familiar with
the term may allow its use as common denominator/
shared language for facilitating interdisciplinary cross-
talks and exchanges. This is really the direction to take to
effectively deal with frailty.
We believe that the only possibility, probably the only
feasible at this time, to manage the growing number of
frail individuals is to remodel healthcare services in order
to privilege and facilitate integrated and multidisciplin-
ary models of care.18 The design of the interventions
around the patient’s needs and resources should thus be
achieved on the basis of a coordinated and collegial dis-
cussion of the case in which the different specialists par-
ticipate with their own expertise and background.
Models of care based on a single-access point (e.g., case-
manager19) and interdisciplinary exchanges formally
nested in clinical services (e.g., orthogeriatric units20)
have already shown their efficacy both for the patient (in
terms of improved quality of life, prevention of negative
health-related outcomes, and higher access to treat-
ments)21,22 and public health (in terms of reduction of
healthcare expenditures).23 Moreover, preliminary
reports have started associating frailty to allocation of
healthcare resources,24 suggesting a higher profile for
this concept in the near future.
Management of geriatric syndromes
The concept of HIV infection as a model of pathological
aging is reinforced by the fact that more than half of the
HIV-infected population presents 2 or more geriatric
syndromes.25 The following paragraphs are not intended
to be exhaustive. The aim is instead to show how fre-
quent detrimental conditions affecting geriatric patients
are found in HIV-positive persons. This population
could therefore greatly benefit from the adapted and per-
sonalized models of care envisioned for older patients.
Falls
Falls (defined as an event which results in a person com-
ing to rest inadvertently on the ground or floor or other
lower level) is a very common condition in older per-
sons. Falls are particularly distressing for the individual,
due to the consequent higher morbidity, loss of physical
function, and increased risk of death, as well as for health
systems.
Hip fracture is the most feared fall-related injury.
Such eventuality is particularly nurtured by the age-
related reduction of bone mineral density. It is notewor-
thy that HIV infection and antiretroviral therapy have
both been associated with significant bone loss, resulting
in osteopenia and osteoporosis.26
In advanced age, falls have typically a multifactorial
etiology, including age-related comorbidities, postural
modifications, sensory impairment, musculoskeletal
weakness, postural hypotension, medications, and envi-
ronmental hazards.27 The prevention of falls conse-
quently requires the multidimensional assessment of a
number of heterogeneous risk factors. It is also impor-
tant to establish if the patient has a history of falls,
because recurrent falls are a major cause of morbidity
and mortality. Moreover, distinct interventions may be
necessary for primary and secondary prevention. Indeed,
once an older person falls, a “post-fall syndrome” may
develop.28 This condition is characterized by the patient’s
fear of new events, leading the individual to unwittingly
modify his/her posture and movements. Such postural
modifications do nothing else that accentuating the risk
of new events through altering the mechanics of move-
ment. A vicious cycle may thus generate that accelerates
the disabling cascade.
Gait and balance evaluation through standardized
tests is a crucial step in primary and secondary fall
prevention. Simply looking at how the patient walks
or sit down/stand-up from a chair may already pro-
vide meaningful information about the risk profile.29
Each comorbidity reported by the patient or detected
during the clinical evaluation should be critically ana-
lyzed as a potential trigger of falls. Sensory deficits
should be corrected whenever possible. Special atten-
tion should be paid to specific medications (e.g., long
half-life benzodiazepines, anticonvulsants, anti-hyper-
tensive drugs) potentially responsible for falls due to
their pharmacodynamics and/or schedule of adminis-
tration. Finally, a successful plan for reducing the risk
of falls cannot ignore the elimination of eventual
environmental hazards (both in the clinical facility
and at the home).
Cognitive impairment and delirium
With the introduction of HAART, neurocognitive disor-
ders in HIV-positive patients have been substantially
reduced although still present. Obviously, HIV-associ-
ated neurocognitive disorders present a pathophysiologi-
cal background completely different from those observed
in older age.30,31
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The mechanisms leading to the HIV-associated neu-
rocognitive disorders are not yet completely clear. Surely,
HIV plays a pivotal role in 1) permitting infected mono-
cytes to pass the blood-brain barrier, 2) turning them
into perivascular macrophages with parallel microglia
activation, and 3) promoting the release of neurotoxic
molecules. The consequence of such events is neuron
demise via the direct actions of viral proteins, or indi-
rectly via apoptosis triggered by the related inflammatory
response.30
Alzheimer disease is traditionally believed to be the
most common cause of dementia at older age. However,
the categorization of different forms of dementia is quite
a complex (and probably meaningless) exercise in
advanced age. In fact, it cannot be ignored that 1) a clear
pathophysiological mechanism for many types of
dementia is not yet defined;32 2) the age-accumulation of
subclinical and clinical deficits leads to a cloud of differ-
ent causes (frequently overlapping and all potentially
valid);7 and 3) no specific treatment able to reverse the
neurodegenerative process (whatever the etiology) is
available to date.
In the case of HIV, the direct link between the viral
infection and neurocognitive disorders lends support to
pharmacological interventions potentially acting at the
very bases of the infectious disease. For example,
although evidence is still limited, antiretroviral drugs
characterized by higher central nervous system penetra-
tion seem to provide some additional benefits in this
context.33 At the same time, it should not be underesti-
mated the importance of multidomain interventions tar-
geting exogenous risk factors. For example, interventions
aimed at assuring social support to the patient, promot-
ing healthier lifestyles, and tackling clinical conditions
(e.g., sensory impairment, cardiovascular risk factors)
potentially accentuating the cognitive decline and other
commonly associated manifestations (e.g., behavioral
and neuropsychiatric symptoms) might represent thera-
peutic commonalities between HIV-associated neuro-
cognitive disorders and neurodegenerative disorders of
advanced age.34 As previously argued, also in this case,
the definition of an optimal plan of intervention, which
will have to necessarily be personalized according to the
patient’s characteristics, should imply a holistic approach
and integrated care.
It is noteworthy that the cognitive impairment related
to HIV infection combined with polypharmacy and
reduced homeostatic reserves may expose the individual
to a high risk of delirium. Delirium is indeed a frequent
neurological complication of HIV infection, especially in
critically ill patients.35 Noticeably, the prevention of
delirium passes through the (often non-pharmacologi-
cal) management of risk factors. Amelioration of sensory
impairments, verification of patient’s hydration, critical
review of drugs prescriptions, and promotion of physical
activity are only few of the habits that every clinician
dealing with frail individuals should familiarize with.36
Sleep disorders
Sleep disorders are frequently listed among the tradi-
tional geriatric syndromes.37 They are also a common
complaint in HIV patients.38 Sleep disorders are a pow-
erful risk factor for physical and cognitive decline, and
able to enhancing the “pathological aging” of an individ-
ual (independently of the HIV infection).
The evidence around the nature of sleep disorders in
HIV-positive patients is still limited, probably because
the problem is underestimated.39 Some reports suggest
that concurrent psychiatric conditions (e.g., depression)
may not completely explain sleep disorders in HIV
patients, proposing that other factors (such as neuronal
damage) may contribute to their pathogenesis.40
Again, in front of a geriatric syndrome (even when
translated in a different field and with potentially diverse
pathophysiological background), it is always important
proceeding with a first multidimensional evaluation
aimed at determining the underlying cause(s). The detec-
tion of the problem might lead to specific diagnostic pro-
cedures (e.g., polysomnographic exam) to guide in the
choice of optimal therapeutic strategies. If sometimes
non-pharmacological interventions (e.g., weight loss,
physical activity, sleep hygiene recommendations) might
be effective, some others special devices (e.g., oral appli-
ances or positive airway pressure for sleep apneas),
surgical interventions (e.g., nasal reconstruction, uvulo-
pharynpalatoplasty) or medications may be needed. In
this latter case, physicians should cautiously prescribe
the lowest effective dose, privilege molecules with shorter
half-life, and follow the patient over time. The risk of
polypharmacy and interactions among drugs is
extremely high in HIV-positive patients, who are chroni-
cally exposed to multiple treatments as any frail and
complex older adult.41 A triage in the choice of interven-
tions is thus needed and should be based on functional
and pragmatic outcomes: quality of life and careful con-
sideration of the altered homeostatic reserves are key fac-
tors for improving prescriptions and strategies.
Polypharmacy
The exposure to polypharmacy, generally defined as the
daily use of 5 or more medications, is an extremely com-
mon and clinically relevant condition in older persons as
well as among HIV-positive patients. In a cornerstone
study of geriatric literature, it was demonstrated that the
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risk of adverse drug reactions is not related to age per se,
but rather to the number of administered medications.42
Surely, the aging process is associated with increasing
“failure to thrive” of the homeostatic mechanisms, conse-
quently rendering the person more vulnerable to the
undesirable effects of drugs.43 With advancing age, the
metabolic capacities of kidneys and liver decline, expos-
ing the individual to the risk of drug intoxication. Such a
risk is also enhanced by the age-related changes in body
composition, characterized by the inversion of the lean
mass-fat mass ratio (even in the presence of a stable
body mass). It is, for example, possible that a lipophilic
medication administered after standardization for body
mass or weight might be overdosed because the metabol-
ically active tissues are reduced and the storage capacities
increased. These crucial aspects to consider when treat-
ing an older person are equally important in HIV-posi-
tive patients. They might be even more important given
the fact that this population is already (chronically)
exposed to HAART agents in addition to those used to
treat comorbidities.
The best way for tackling polypharmacy is to reduce
inappropriate prescriptions. Specific guidelines and recom-
mendations for “de-prescribing” are available in literature.44
In general, clinicians should carefully evaluate the
list of drugs taken daily by older persons and HIV-
positive patients. During the evaluation process, it is
crucial that the physician is not driven at treating
every single abnormality. Such an approach would
easily conduct to overtreatment and risk of adverse
drug reactions. The choice of a treatment should be
judged on the basis of realistic and practical objec-
tives, while maintaining a holistic vision of priori-
ties.45 By doing so, it is important to keep in mind
that evidence for commonly used drugs is often
derived from trials conducted in different (healthier)
populations.46 Moreover, in older persons and in
HIV-positive patients, it is also important to explore
social and economic issues potentially affecting the
patient’s adherence and compliance to the therapeutic
recommendations in order to reduce the risk of
adverse drug reactions. For this reason, it is always
wise to check the medications really taken by the
patient at every clinical contact. Some evidence sup-
ports the benefits deriving from the adoption of com-
puter-based prescribing systems.41 Indeed, software
applying specific algorithms for supporting the appro-
priateness of drugs prescription have shown to
improve the healthcare provider’s behavior. Unfortu-
nately, evidence about the beneficial effect of these
systems on the patient’s outcomes is still very limited.
The clinician should also try to simplify as much as
possible the drug prescriptions, both in terms of number
of medications and their daily schedule. In this context,
the use of combined drugs might be helpful, but only if
allowing adequate calibration of the single molecules
according to the individual’s reserves. The general rule to
follow in geriatric population and also applicable to frail
HIV-positive patients is “Start low, go slow.”47
Mobility impairment and functional limitation
Mobility is a basic function present in almost every living
being. The incapacity to move has been related to nega-
tive health-related outcomes across species.48 It is note-
worthy that physical performance has repeatedly been
considered as a marker of wellbeing. Its decline is closely
related to the loss of the biological homeostasis of an
organism as a whole. Thus, it is not surprising that indi-
viduals experiencing an accelerated and/or accentuated
aging process are also characterized by impaired
mobility.
Besides serving as an important marker to estimate
the biological age of a person, mobility impairment also
defines a major clinical outcome for older adults.49 In
fact, mobility disability is considered the first step of the
disabling cascade, a condition to be prevented before the
vicious circle of frailty-disability becomes more difficult
to be halted.
The age-related impairment of the mechanisms
devoted to mobility is multi-causal. Although the quanti-
tative and qualitative decline of skeletal muscle (often
referred to as “sarcopenia”) may represent the organ-
specific impairment responsible for the loss of mobility
with advancing age, it is indeed difficult to indicate one
single cause for the syndromic manifestation of mobility
impairment. For example, sensory deficits as well as
environmental factors may easily explain the worsening
of mobility.
A recent systematic review showed that mobility and
motor function disability is highly prevalent (about 25%)
among people living with HIV in sub-Saharan Africa.50
HIV-positive patients receiving combination antiretrovi-
ral therapy frequently present specific body composition
modifications (i.e., “lipodystrophy syndrome”), charac-
terized by adipose tissue redistribution. Interestingly,
central obesity has shown to be a strong predictor of
frailty in community-dwelling older persons with HIV
and to significantly impact physical performance meas-
ures.51 Moreover, lipodystrophy is often accompanied by
a reduction of bone quality,52 which can further contrib-
ute to undermine the structure of the organism,53 leading
to a decline of function.
To date, the only intervention able to positively affect
mobility impairment is physical exercise. The Lifestyle
Interventions and Independence for Elders (LIFE) trial
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has recently showed that a long-term structured physical
activity is able to prevent mobility disability in older per-
sons with physical function impairment.54 Similar results
have been reported in preliminary studies recruiting
HIV-positive patients.55 A physical activity program
should always be proposed in parallel with nutritional
counseling in order to meet the new (increased) energy
demands and provide adequate protein intake to pro-
mote muscle growth and strengthening. It is indeed
important to stress how lifestyle modifications are crucial
and should be part of the HIV therapy.
Mobility impairment is usually considered to be the
first stage of the disabling process. After losing the capac-
ity to cover the necessary walking distance for maintain-
ing independent life (traditionally estimated in 400 m
56,57), the individual usually tends to develop additional
disabilities: first in the accomplishment of instrumental
activities of daily living (IADL), then in the execution of
basic activities of daily living (ADL). The gradual loss of
these capacities makes the clinical management increas-
ingly challenging because of 1) the instauration of a det-
rimental vicious cycle, and 2) socio-economic barriers
becoming more relevant and evident. For these reasons,
the care of individuals with functional limitations
requires a multidisciplinary team working in a dedicated
network well nested in the territory. Actions aimed at
treating disabilities and/or preventing further decline
should foresee personnel dedicated to the identification
of the underlying causes, the clinical management, and
the close follow-up of the patient. Such strategy has
shown to be particularly effective in the geriatric popula-
tion when the members of the team (e.g., physician,
nurse, physical therapist, social worker, etc.) work syner-
gistically using shared information and closely monitor-
ing the patient’s clinical modifications.22
How to incorporate geriatrics in the care of HIV
patients
The increasing age of patients across multiple medical
disciplines (not only in care settings for HIV) is challeng-
ing the sustainability of traditional healthcare systems.
The old-fashioned models of care based on single dis-
eases are no longer functional. In order to tackle the spe-
cial needs brought by the “gray tsunami,” it is important
to shift toward different paradigms based on syndromes,
chronic conditions, multimorbid individuals, and per-
son-tailored interventions.16 Such mind setting is crucial
for geriatric care and should be better nested in the train-
ing of healthcare professionals. In our “gray societies,” it
is not anymore acceptable that the study of aging (and of
its consequences) is only marginally included in the
education curricula and often used for only justifying
nosographic conditions.6,58
In the specific field of HIV, geriatric care might be
promoted by facilitating interdisciplinary exchanges
between geriatricians and infectious disease specialists.
As mentioned above, the development of structured col-
laborations mirroring previous successful experiences
(e.g., orthogeriatric wards)59,60 might represent a first
promising (and not invasive) strategy. Surely, the special
features of HIV-positive patients may require the design
of ad hoc new tools for supporting the clinical assessment
of this new frail population. In fact, the instruments used
in geriatric medicine are based on scopes, criteria, and
cut-points which are likely not applicable (or relevant) to
HIV-positive patients. Nevertheless, geriatricians can
provide the background and initial models for building
up specific tools aimed at capturing the clinical complex-
ity and peculiarities of the frail HIV-positive patients.
For example, some studies conducted in HIV-positive
patients have started using the Frailty Index developed
by Rockwood and Mitniski 61,62 with the aim of measur-
ing the individual’s “biological age” and predicting nega-
tive outcomes.63 Being based on arithmetic and not
clinical assumptions, this instrument is more suitable
than others for an immediate translation of the frailty
concept from geriatrics to the IDM world given its quan-
titative nature. Differently, other instruments structured
around specific socio-demographic, biological, and clini-
cal features may require adaptations before being imple-
mented in the new setting, but may still provide ground
for thinking.64
Conclusions
The growing prevalence and incidence of geriatric syn-
dromes across medical disciplines is a sign of the socio-
economic and cultural advances of our societies. At the
same time, global aging is substantially modifying the
scenarios where clinical practice is conducted. Clinical
decisions are indeed extremely complex in biologically
aged individuals and, as such, require multidisciplinary
input. Healthcare systems are therefore called to aban-
don traditional paradigms in favor of new models of care
in order to accommodate novel needs and demands.
Such an endeavor may take advantage of the wealth of
experience accrued by geriatricians over the last
decades.6
The birth of clinical services convening healthcare
professionals from multiple disciplines might be a prom-
ising venture to pursue, following the successful experi-
ence of other “mixed” clinical units. If medical specialties
will continue to work in parallel without combining their
expertise for the care of multimorbid and frail elders,
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current healthcare systems will simply collapse. Such a
revision is particularly urgent in those disciplines, like
IDM, which increasingly face the management of geriat-
ric syndromes in biologically aged individuals.
On the other hand, the transposition of the geriatric
background to other disciplines is a difficult task to
accomplish, especially because geriatric medicine does
not typically operate under definitive rules. Older
patients represent an extremely heterogeneous popula-
tion, in which medical complexity is not determined by
chronological age. The implementation of geriatric care
in HIV clinics therefore requires the acceptance of new
paradigms in the personalization of pharmacological and
non-pharmacological interventions.
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